Gilead's growing pains; opioid crisis victims address Purdue owners

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      Listen: Gilead's growing pains, Covid's origins, & Theranos as prestige TV By Damian Garde and Meg Tirrell and Adam Feuerstein This week, we examine Gilead Sciences' recent struggles and what the company's predicament says about the drug industry. Read More As providers are accused of interfering with access to patient data, pressure builds on government to act By Mohana Ravindranath Adobe Health tech leaders and former federal officials are calling for a more aggressive approach to instances of "information blocking." Read More 'Scum of the earth': Opioid crisis victims face Purdue Pharma owners By Geoff Mulvihill and Jennifer Peltz — Associated Press Josh Reynolds/AP The hearing gave victims and survivors the chance to confront members of the Sackler family who own OxyContin maker Purdue Pharma. Read More Sponsor content by ICON CLINICAL RESEARCH Advanced clinical solutions powered by healthcare intelligence — delivered seamlessly ICON is the world's largest and most comprehensive clinical research organization, powered by Healthcare Intelligence. Leveraging their human expertise, robust clinical capabilities, and insightful data resources, ICON is expanding the possibilities of clinical research without sacrificing the vital, day-to-day functions of today's CROs. Learn more. 'It's not medical': Oregon wrestles with how to offer psychedelics outside the health care system By Olivia Goldhill Ayşe Gürsöz for STAT The psychedelic legalization movement is progressing parallel to a gold rush to develop these same drugs as medicine. Read More Thursday, March 10, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser